(Bloomberg) — Emerging-market equities and currencies rose for a third week amid optimism over progress toward a coronavirus vaccine. Moderna Inc. and Pfizer Inc. announced promising clinical trial results even as countries from the U.S. to Japan imposed stricter restrictions to combat the infection. Turkey’s central bank raised interest rates, boosting the lira, while authorities in Indonesia and the Philippines unexpectedly cut borrowing…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.